Systemic lupus: basic mechanisms and prospects for specific immunotherapy

REFERENCES

• Boumpas DT, Austin HA, Fessler BJ et al: Systemic lupus erythematosus: emerging concepts. Part 1: renal, neuropsychyatric, cardiovascular, pulmonary and hematologic disease. Ann Int Med 122: 940–950, 1995.
   PubMed Web of Science ®Google Scholar
• Harley JB, Sestak AL, Willis LG et al: A model for disease heterogeneity in systemic lupus erythematosus: relationships between histocompatibility antigens, autoantibodies, and lymphopenia or renal disease. Arthritis Rheum 32: 826–836, 1989.
   PubMed Web of Science ®Google Scholar
• Salmon JE, Millard S, Schachter LA et al: FcYRIIA alleles are heritable risk factors for lupus nephritis in African Americans. J Clin Invest 97: 1348–1354, 1996.
   PubMed Web of Science ®Google Scholar
• Mohan C, Datta SK: Lupus: key pathogenic mechanisms and contributing factors. Clin Immunol Immunopathol 77: 209–220, 1995.
   Google Scholar
• Tan EM: Anti-nuclear antibodies: diagnostic markers for autoimmunity diseases and probes for cell biology. Adv Immunol 44: 93–151, 1989.
   PubMed Web of Science ®Google Scholar
• Hardin JA, Thomas JO: Antibodies to histones in systemic lupus erythematosus: localization of prominent autoantigens on histone HI and H2B. Proc Natl Acad Sci USA 80: 7410–7414, 1983.
   PubMed Web of Science ®Google Scholar
• Casciola-Rosen LA, Anhalt G, Rosen A: Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 179: 1317–1330, 1994.
   PubMed Web of Science ®Google Scholar
• Stewart A, Huang C, Long A et al: VH-gene representation in autoantibodies reflects the normal B cell repertoire. Immunol Rev 128: 101–122, 1992.
   PubMed Web of Science ®Google Scholar
• Madaio MP, Hodder S, Schwartz RS et al: Responsiveness of autoimmune and normal mice to nucleic acid antigens. J Immunol 132: 872–876, 1984.
   PubMed Web of Science ®Google Scholar
• Gilkeson GS, Pippen AMM, Pisetsky DS: Induction of cross-reactive anti-dsDNA antibodies in preau-toimmune NZB/NZW mice by immunization with bacterial DNA. J Clin Invest 95: 1398–1402, 1995.
   PubMed Web of Science ®Google Scholar
• Datta SK, Mohan C, Desai-Mehta A: Mechanisms of the pathogenic autoimmune response in lupus: prospects for specific immunotherapy. Immunol Res 14: 132–147, 1995.
   Google Scholar
• Howie JB, Helyer BJ: The immunology and pathology of NZB mice. Adv Immunol 9: 215–268, 1968.
   PubMedGoogle Scholar
• Datta SK, Schwartz RS: Genetics of expression of xenotropic virus and autoimmunity in NZB mice. Nature 263: 412–415, 1976.
   Google Scholar
• Datta SK, Schwartz RS: Mendelian segregation of loci controling xenotropic virus production in NZB crosses. Virology 83: 449–452, 1977.
   Google Scholar
• Datta SK, Manny N, Andrzejewski C, Andre-Schwartz J, Schwartz RS: Genetic studies of autoimmunity and retrovirus expression in crosses of New Zealand Black mice. I. Xenotropic virus. J Exp Med 147: 854–871, 1978.
   Google Scholar
• Datta SK, McConahey PJ, Manny N et al: Genetic studies of autoimmunity and retrovirus expression in crosses of NZB mice. JJ. The viral envelope glycoprotein gp 70. J Exp Med 147: 872–881, 1978.
   Google Scholar
• Eastcott JW, Schwartz RS, Datta SK: Genetic analysis of the inheritence of B cell hyperactivity in relation to the development of autoantibodies and glomerulonephritis in NZB x SWR crosses. J Immunol 131: 2232–2239, 1983.
   PubMed Web of Science ®Google Scholar
• Datta SK: A search for the underlying mechanisms of systemic autoimmune disease in the NZB x SWR model. Clin Immunol Immunopathol 51: 141–156, 1989.
   PubMedGoogle Scholar
• Sercarz EE, Datta SK: Mechanisms of autoimmunization: perspective from the mid-90s. Curr Opin Immunol 6: 875–881, 1994.
   Google Scholar
• Drake CG, Babcock SK, Palmer E et al: Genetic analysis of the NZB contribution to lupus-like autoimmune disease in (NZB x NZW)F1 mice. Proc Natl Acad Sci USA 91: 4062–4066, 1994.
   PubMed Web of Science ®Google Scholar
• Morel L, Rudofsky UH, Longmate JA et al: Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity 1: 219–229, 1994.
   PubMed Web of Science ®Google Scholar
• Kono DH, Burlingame RW, Owens DG et al: Lupus susceptibility loci in New Zealand mice. Proc Natl Acad Sci USA 91: 10168–10172, 1994.
   PubMed Web of Science ®Google Scholar
• Kelly VE, Winkelstein A: Age and sex-related glomerulonephritis in New Zealand white mice. Clin Immunol Immunopathol 16: 142–150, 1980.
   Google Scholar
• Yoshiki T, Mellors RC, Strand M et al.: The viral envelope glycoprotein of murine leukemia virus and the pathogenesis of immune complex glomerulonephritis of New Zealand Mice. J Exp Med 140: 1011–1027, 1974.
   PubMed Web of Science ®Google Scholar
• Schwartz RS: Viruses and systemic lupus erythematosus. N Engl J Med 293: 132–138, 1975.
   Google Scholar
• Lewis RM, Tannenberg W, Smith C et al: C-type viruses and systemic lupus erythematosus. Nature 252: 78–79, 1974.
   PubMed Web of Science ®Google Scholar
• Talal N: Immunologic and viral factors in the pathogenesis of systemic lupus erythematosus. Arthritis Rheum 13: 887–894, 1970.
   PubMedGoogle Scholar
• Lambert PH, Dixon FJ: Genesis of anti-nuclear antibody in NZB/W mice: role of genetic factors and of viral infections. Clin Exp Immunol 6: 829–839, 1970.
   PubMed Web of Science ®Google Scholar
• Levy JA: Xenotropic C-type viruses and autoimmune disease. J Rheumatol 2: 135–148, 1975.
   Google Scholar
• Panem S, Ordonez NG, Kerstein WH et al.: C-type virus expression in systemic lupus erythematosus. N Engl J Med 295: 470–475, 1976.
   PubMedGoogle Scholar
• Mellors RC, Mellors JW: Antigen related to mammalian type-C RNA viral p30 proteins is located in renal glomeruli in human systemic lupus erythematosus. Proc Natl Acad Sci USA 73: 233–237, 1976.
   PubMed Web of Science ®Google Scholar
• Markenson JA, Phillips PE: Type-C viruses in systemic lupus erythematosus. Arthritis Rheum 21: 266–270, 1978.
   Google Scholar
• Strand M, August JT: Type-C RNA virus gene expression in human tissue. J Virol 14: 1584–1596, 1974.
   Google Scholar
• Krieg AM, Steinberg AD: Analysis of thymic endogenous retroviral expression in murine lupus. Genetic and immune studies. J Clin Invest 86: 809–816, 1990.
   Google Scholar
• Datta SK, Owen FL, Womack JE et al.: Analysis of recombinant inbred lines derived from autoimmune (NZB) and high leukemia (C58) strains: independent multigenic systems control B cell hyperactivity, retrovirus expression and autoimmunity. J Immunol 129: 1539–1544, 1982.
   Google Scholar
• Pisetsky DS, McCarty GA, Peters DV: Mechanisms of autoantibody production in autoimmune MRL mice. J Exp Med 152: 1302–1310, 1980.
   PubMed Web of Science ®Google Scholar
• Cohen PL, Eisenberg RA: Anti-idiotypic antibodies to the Coomb’s antibody in NZB Fl mice. J Exp Med 156: 173–180, 1982.
   PubMed Web of Science ®Google Scholar
• Chiang B-L, Bearer E, Ansari A et al.: The bml2 mutation and autoantibodies to dsDNA in NZB.H-2bml2 mice. J Immunol 145: 94–101, 1990.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Hirose S, Hamano Y et al.: Mapping of a gene for the increased susceptibility of Bl cells to Mott cell formation in murine autoimmune disease. J Immunol 158: 992–997, 1997.
   PubMed Web of Science ®Google Scholar
• Gavalchin J, Nicklas J, Eastcott JW et al.: Lupus prone (SWR x NZB)F1 mice produce potentially nephritogenic autoantibodies inherited from the normal SWR parent. J Immunol 134: 885–894, 1985.
   PubMed Web of Science ®Google Scholar
• Gavalchin J, Seder RA, Datta SK: The NZB x SWR model of lupus nephritis. I. Cross-reactive idiotypes of monoclonal anti-DNA antibodies in relation to antigenic specificity, charge and allotype. Identification of interconnected idiotype families inherited from the normal SWR and the autoimmune NZB parents. J Immunol 138: 128–137, 1987.
   PubMed Web of Science ®Google Scholar
• Gavalchin J, Datta SK: The NZB x SWR model of lupus nephritis. II. Autoantibodies deposited in renal lesions show a restricted idiotypic diversity. J Immunol 138: 138–148, 1987.
   PubMed Web of Science ®Google Scholar
• Datta SK, Gavalchin J: The origins of pathogenic anti-DNA idiotypes in the (NZB x SWR)F1 model of lupus nephritis. Ann NY Acad Sci 475: 47–58, 1986.
   PubMed Web of Science ®Google Scholar
• Datta SK, Patel H, Berry D: Induction of a cationic shift in IgG anti-DNA autoantibodies. Role of T helper cells with classical and novel phenotypes in three murine models of lupus nephritis. J Exp Med 165: 1252–1268, 1987.
   PubMed Web of Science ®Google Scholar
• Shivakumar S, Tsokos GC, Datta SK: T cell receptor a/fi expressing double negative (CD4_/CD8~) and CD4+ T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis. J Immunol 143: 103–112, 1989.
   PubMed Web of Science ®Google Scholar
• Vlahakos DV, Foster MH, Adams S et al.: Anti-DNA antibodies form immune deposits at distinct glomerular and vascular sites. Kidney Int 41: 1690–1700, 1992.
   PubMed Web of Science ®Google Scholar
• O’Keefe TL, Bandyopadhyay S, Datta SK et al: variable region sequences of an idiotypically connected family of pathogenic anti-DNA autoantibodies. J Immunol 144: 4275–4283, 1990.
   Google Scholar
• Tillman DM, Jou N-T, Hill RJ et al: Both IgM and IgG anti-DNA antibodies are the products of clonally selective B cell stimulation in (NZB x NZW)F1 mice. J Exp Med 176: 761–779, 1992.
   PubMed Web of Science ®Google Scholar
• Shlomchik MJ, Mascelli M, Shan H et al.: Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation. J Exp Med 171: 265–292, 1990.
   PubMed Web of Science ®Google Scholar
• Tsao BP, Ebling FM, Roman C et al.: Structural characteristics of the variable regions of immunoglobulin genes encoding a pathogenic autoantibody in murine lupus./Clin <i>Invest 85: 530–540, 1990.
   Google Scholar
• Kieber-Emmons T, Foster MH, Williams WV et al.: Structural properties of a subset of nephritogenic anti-DNA antibodies. Immunol Res 13: 172–185, 1994.
   Google Scholar
• Diamond B, Katz JB, Paul E et al.: The role of somatic mutation in the pathogenic anti-DNA response. Annu Rev Immunol 10: 731–757, 1992.
   PubMed Web of Science ®Google Scholar
• Radic MZ, Weigert M: Genetic and structural evidence for antigen selection of anti-DNA antibodies. Annu Rev Immunol 12: 487–520, 1994.
   PubMed Web of Science ®Google Scholar
• Ebling F, Hahn BH: Restricted subpopulations of DNA antibodies in kidneys of mice with systemic lupus: comparison of antibodies in serum and renal eluates. Arthritis Rheum 23: 392–403, 1980.
   PubMed Web of Science ®Google Scholar
• Gauthier VJ, Mannik M: A small proportion of cationic antibodies in immune complexes is sufficient to mediate their deposition in glomeruli. J Immunol 145: 3348–3352, 1990.
   PubMed Web of Science ®Google Scholar
• Schmiedke TMJ, Stockl FW, Weber R et al: Histones have high affinity for the glomerular basement membrane. Relevance for immune complex formation in lupus nephritis. J Exp Med 169: 1879–1894, 1989.
   Google Scholar
• Kramers C, Hylkema MN, van Bruggen MCJ et al: Anti-nucleosome antibodies complexed to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular basement membrane in vivo. J Clin Invest 94: 568–577, 1994.
   PubMed Web of Science ®Google Scholar
• Mohan C, Adams S, Stanik V et al.: Nucleosome: a major immunogen for the pathogenic autoanti-body-inducing T cells of lupus. J Exp Med 177: 1367–1381, 1993.
   PubMed Web of Science ®Google Scholar
• Ohnishi K, Ebling FM, Mitchell B et al: Comparison of pathogenic and non-pathogenic murine antibodies to DNA: antigen binding and structural characteristics. Int Immunol 6: 817–827, 1994.
   PubMed Web of Science ®Google Scholar
• Suenaga R, Abdou NI: Cationic and high affinity serum IgG anti-dsDNA antibodies in active lupus nephritis. Clin Exp Immunol 94: 418–422, 1993.
   PubMed Web of Science ®Google Scholar
• Suzuki N, Harada T, Mizushima Y et al: Possible pathogenic role of cationic anti-DNA autoantibodies in the development of nephritis in patients with systemic lupus erythematosus. J Immunol 151: 1128–1136, 1993.
   PubMed Web of Science ®Google Scholar
• Winkler TH, Fehr H, Kalden JR: Analysis of immunoglobulin variable region genes from human IgG anti-DNA hybridomas. Eur J Immunol 22: 1719–1728, 1992.
   PubMed Web of Science ®Google Scholar
• Ghatak S, Sainis K, Owen FL et al: T cell receptor /? and I-Aj8 chain genes of normal SWR mice are linked with the development of lupus nephritis in NZB x SWR crosses. Proc Natl Acad Sci USA 84: 6850–6853, 1987.
   PubMed Web of Science ®Google Scholar
• O’Keefe TL, Datta SK, Imanishi-Kari T: Cationic residues in pathogenic anti-DNA autoantibodies arise by mutations of a germline gene that belongs to a large VH gene subfamily. Eur J Immunol 22: 619–624, 1992.
   PubMed Web of Science ®Google Scholar
• Rajagopalan S, Zordan T, Tsokos GC et al: Pathogenic anti-DNA autoantibody inducing T helper cell lines from patients with active lupus nephritis: Isolation of CD4- /CD8~ T helper cell lines that express the y/S T cell receptor. Proc Natl Acad Sci USA 87: 7020–7024, 1990.
   PubMed Web of Science ®Google Scholar
• Sainis K, Datta SK: CD4+ T cell lines with selective patterns of autoreactivity as well as CD4~/CD8~ T helper cell lines augment the production of idiotypes shared by pathogenic anti-DNA autoantibodies in the NZB x SWR model of lupus nephritis. J Immunol 140: 2215–2224, 1988.
   PubMedGoogle Scholar
• Adams S, Zordan T, Sainis K et al: T cell receptor V^ genes exspressed by IgG anti-DNA autoantibody inducing T cells in lupus nephritis: forbidden receptors and double negative T cells. Eur J Immunol 20: 1435–1443, 1990.
   Google Scholar
• Adams S, Leblanc P, Datta SK: Junctional region seuences of T-cell receptor fi chain genes expressed by pathogenic anti-DNA autoantibody-inducing T helper cells from lupus mice: Possible selection by cationic autoantigens. Proc Natl Acad Sci USA 88: 11271–11275, 1991.
   Google Scholar
• Mao C, Osman GE, Adams S et al: T cell receptor alpha-chain repertoire of pathogenic autoantibody-inducing T cells in lupus mice. J Immunol 152: 1462–1470, 1994.
   Google Scholar
• Desai-Mehta A, Mao C, Rajagopalan S et al: Structure and specificity of T-cell receptors expressed by pathogenic anti-DNA autoantibody-inducing T cells in human lupus. J Clin Invest 95: 531–541, 1995.
   PubMed Web of Science ®Google Scholar
• Jorgensen JL, Esser U, Reay PA et al: Mapping T cell receptor/peptide contacts by variant peptide immunization of single-chain transgenics. Nature 355: 224–230, 1992.
   PubMed Web of Science ®Google Scholar
• Atkinson MJ, Bell DA, Singhal SK: A naturally occuring polyclonal B cell activator of normal and autoantibody responces. J Immunol 135: 2524–2533, 1985.
   PubMed Web of Science ®Google Scholar
• Datta SK, Rajagopalan S, O’Keefe TL et al: Pathogenic anti-DNA autoantibodies and pathogenic autoantibody-inducing T cells. In Molecular Immunobiology of Self-Reactivity (Bona CA, Kaushik A, Eds), pp. 133–153. Marcel Decker, New York, 1992.
   Google Scholar
• Rumore P, Steinman C: Endogenous circulating DNA in systemic lupus erythematosus. Occurrences as multimeric complexes bound to histones. J Clin Invest 86: 69–74, 1990.
   PubMed Web of Science ®Google Scholar
• Fournie GJ, Lule J, Dueymes J-M et al: Plasma DNA in patients undergoing hemodialysis at hemofil-tration: cytolysis in artificial kidney is responsible for the release of DNA in circulation. Am J Nephrol 9: 384–391, 1989.
   PubMedGoogle Scholar
• Atanassov C, Briand JP, Bonnier D et al: New Zealand white rabbits immunized with RNA-complexed total histones develop an autoimmune-like response. Clin Exp Immunol 86: 124–133, 1991.
   PubMedGoogle Scholar
• Rothfield NF, Stollar BD: The relation of immunoglobulin class, pattern of anti-nuclear antibody, and complement-fixing antibodies to DNA in sera from patients with systemic lupus erythematosus. J Clin Invest 46: 1785–1794, 1967.
   PubMed Web of Science ®Google Scholar
• Burlingame RW, Rubin RL, Balderas RS et al: Genesis and evolution of antichromatin autoantibodies in murine lupus implicates immunization with self antigen. J Clin Invest 91: 1687–1696, 1993.
   PubMed Web of Science ®Google Scholar
• Burlingame RW, Boey ML, Starkebaum G et al: The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus. J Clin Invest 94: 184–192, 1994.
   PubMed Web of Science ®Google Scholar
• Chabre H, Amoura Z, Piette J-C et al: Presence of nucleosome-restricted antibodies in patients with systemic lupus erythematosus. Arthritis Rheum 38: 1485–1491, 1995.
   PubMedGoogle Scholar
• Bernstein KA, DiValerio R, Lefkowith JB: Glomerular binding activity in MRL Ipr serum consists of antibodies that bind to a DNA/histone/type IV collagen complex. J Immunol 154: 2424–2433, 1995.
   PubMedGoogle Scholar
• O’Hehir RE, Garman RD, Greenstein JL et al: The specificity and regulation of T cell responsiveness to allergens. Ann Rev Immunol 9: 67–95, 1991.
   PubMed Web of Science ®Google Scholar
• Kaliyaperumal A, Mohan C, Wu W et al: Nucleosomal peptide epitopes for nephritis-inducing T helper cells of murine lupus. J Exp Med 183: 2459–2469, 1996.
   PubMed Web of Science ®Google Scholar
• Rothstein TL, Wang JKM, Panka DJ et al: Protection against Fas-dependent Th-1 mediated apoptosis by antigen receptor engagement in B cells. Nature 374: 163–165, 1995.
   PubMed Web of Science ®Google Scholar
• Suda T, Nagata S: Purification and characterization of the Fas-ligand that induces apoptosis. J Exp Med 179: 873–879, 1994.
   PubMed Web of Science ®Google Scholar
• Singh RR, Hahn BH, Sercarz EE: Neonatal peptide exposure can prime T cells and upon subsequent immunization, induce their immune deviation: implications for antibody vs. T cell-mediated immunity. J Exp Med 183: 1613–1622, 1996.
   PubMed Web of Science ®Google Scholar
• Nakajima A, Hiroshe S, Yagita H et al: Roles of IL-4 and EL-12 in the development of lupus in NZB/W Fl mice. J Immunol 158: 1466–1472, 1997.
   PubMed Web of Science ®Google Scholar
• Elkon KB, Marshak-Rothstein A: B cells in systemic autoimmune disease: recent insights from Fas-deficient mice and men. Curr Opin Immunol 8: 852–859, 1996.
   PubMed Web of Science ®Google Scholar
• Datta SK, Kaliyaperumal A: Nucleosome-driven autoimmune response in lupus — pathogenic T helper cell epitopes and costimulatory signals. Ann NY Acad Sci 815: 155–170, 1997.
   Google Scholar
• Lake P, Mitchison NA: Regulatory mechanisms in the immune response to cell-surface antigens. Cold Spring Harbor Symp Quant Biol 41: 589–595, 1976.
   Google Scholar
• Lehman P, Forsthuber T, Miller T et al: Spreading of T cell autoimmunity to cryptic determinants of an autoantigen. Nature 358: 155–157, 1992.
   PubMed Web of Science ®Google Scholar
• Ando DG, Sercarz EE, Hahn BH: Mechanisms of T and B cell collaboration in the in vitro production of anti-DNA antibodies in the NZB/NZW Fl murine SLE model. J Immunol 138: 3185–3190, 1987.
   PubMed Web of Science ®Google Scholar
• Sobel ES, Kakkanaiah VN, Kakkanaiah M et al: T-B collaboration for autoantibody production in Ipr mice is cognate and MHC-restricted. J Immunol 152: 6011–6016, 1994.
   PubMed Web of Science ®Google Scholar
• Naiki M, Chiang B-L, Cawley D et al: Generation and characterization of cloned helper T cell lines for anti-DNA responses in NZB.H-2bml2 mice. J Immunol 149: 4109–4115, 1992.
   PubMedGoogle Scholar
• Portanova JP, Arndt RE, Kotzin BL: Selective production of autoantibodies in graft-versus-host induced and spontaneous murine lupus. Predominant reactivity with histone regions accessible in chromatin. J Immunol 140: 755–760, 1988.
   Google Scholar
• Mamula MJ, Fatenejad S, Craft J: B cells process and present lupus autoantigens that initiate autoimmune T cell responses. J Immunol 152: 1453–1461, 1994.
   PubMed Web of Science ®Google Scholar
• James JA, Gross T, Scofield RH et al: Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: Sm B/B’-derived PPPGMRPP and PPPGIRGP induce spliceosome autoimmunity. J Exp Med 181: 453–461, 1995.
   PubMedGoogle Scholar
• Desai DD, Krishnan MR, Swindle JT et al: Antigen-specific induction of antibodies against native mammalian DNA in nonautoimmune mice. J Immunol 151: 1614–1626, 1993.
   PubMed Web of Science ®Google Scholar
• Kanai Y, Takeda O, Kanai Y et al: Novel autoimmune phenomena induced in vivo by a new DNA binding protein Nuc: a study on MRL/n mice. Immunol Lett 39: 83–89, 1994.
   Google Scholar
• Fredriksen K, Osei A, Sundsfjord A et al: On the biological origin of anti-dsDNA antibodies: systemic lupus erythematosus related anti-dsDNA antibodies are induced by polyomavirus BK in lupus-prone (NZB x NZW)F1 hybrids, but not in normal mice. Eur J Immunol 24: 66–70, 1994.
   Google Scholar
• Moens U, Seternes O-M, Hey AW et al: In vivo expression of a single viral DNA-binding protein generates systemic lupus erythematosus-related autoimmunity to double-stranded DNA and histones. Proc Natl Acad Sci USA 92: 12393–12397, 1995.
   PubMed Web of Science ®Google Scholar
• Noelle RJ, Ledbetter JA, Aruffo A: CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B cell activation. Immunol Today 13: 431–433, 1992.
   PubMedGoogle Scholar
• Lederman S, Yellin MJ, Inghirami G et al: Molecular interaction mediating T-B lymphocyte collaboration in human lymphoid follicles. Role of T cell -B cell activating molecule (5c8 antigen) and CD40 in contact-dependent help. J Immunol 149: 3817–3826, 1992.
   PubMed Web of Science ®Google Scholar
• Clark EA, Ledbetter JA: How B and T cells talk to each other. Nature 367: 425–428, 1994.
   PubMed Web of Science ®Google Scholar
• Roy M, Waldschmidt T, Aruffo A et al: The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells. J Immunol 151: 2497–2510, 1993.
   PubMed Web of Science ®Google Scholar
• Banchereau J, Bazan F, Blanchard D et al: The CD40 antigen and its ligand. Anna Rev Immunol 12: 881–922, 1994.
   PubMed Web of Science ®Google Scholar
• Spriggs MK, Armitage RJ, Stockbine L et al: Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion. J Exp Med 176: 1543–1550, 1992.
   PubMed Web of Science ®Google Scholar
• Mohan C, Shi Y, Laman JD et al: Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. J Immunol 154: 1470–1480, 1995.
   PubMed Web of Science ®Google Scholar
• Desai-Mehta A, Lu L, Ramsey-Goldman R et al: Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J Clin Invest 97: 2063–2073, 1996.
   PubMed Web of Science ®Google Scholar
• Durie FH, Fava RA, Foy TM et al: Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science 261: 1328–1330, 1993.
   PubMed Web of Science ®Google Scholar
• Durie FH, Aruffo A, Ledbetter J et al: Antibody to ligand of CD40, gp39, blocks the occurence of the acute and chronic forms of graft-versus-host disease. J Clin Invest 94: 1333–1338, 1994.
   PubMed Web of Science ®Google Scholar
• Hill A, Chapel H: X-linked immunodeficiency. The fruits of cooperation. Nature 361: 494, 1993.
   Google Scholar
• Singh RR, Kumar V, Ebling FM et al.: T cell determinants from autoantibodies to DNA can upreg-ulate autoimmunity in murine SLE. J Exp Med 181: 2017–2027, 1995.
   PubMedGoogle Scholar
• Early GS, Zhao W, Burns CM: Anti-CD40 ligand antibody treatment prevents the development of lupus-like nephritis in a subset of New Zealand Black x New Zealand White mice: Response correlates with the absence of an anti-antibody response. J Immunol 157: 3159–3164, 1996.
   PubMed Web of Science ®Google Scholar
• Yellin MJ, D’Agati V, Parkinson G et al: Immunohistologic analysis of renal CD40 and CD40L expression in lupus nephritis and other glomerulonephritides. Arthritis Rheum 40: 124–134, 1997.
   PubMedGoogle Scholar
• Koshy M, Berger D, Crow MK: Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes. J Clin Invest 98: 826–837, 1996.
   PubMed Web of Science ®Google Scholar
• Grammer AC, Bergman MC, Miura Y et al: The CD40 ligand expressed by human B cells costim-ulates B cell responses. J Immunol 154: 4996–5010, 1995.
   PubMed Web of Science ®Google Scholar
• Facchetti F, Appiani C, Salvi L et al: Immunohistologic analysis of ineffective CD40-CD40 ligand interaction in limphoid tissues from patients with X-linked immunodeficiency with hyper-IgM. Abortive germinal center cell reaction and severe depletion of follicular dendritic cells. J Immunol 154: 6624–6633, 1995.
   PubMed Web of Science ®Google Scholar
• Ware CF, Crowe PD, Vanarsdale TL et al: Tumor necrosis factor (TNF) receptor family expression in T lymphocytes. Differential regulation of the type I TNF receptor during activation of resting and effector T cells. J Immunol 147: 4229–4238, 1991.
   PubMed Web of Science ®Google Scholar
• Ranheim EA, Kipps TJ: Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J Exp Med 177: 925–935, 1993.
   PubMed Web of Science ®Google Scholar
• Kennedy MK, Mohler KM, Shanebeck KD et al.: Induction of B cell costimulatory function by recombinant murine CD40 ligand. Eur J Immunol 24: 116–123, 1994.
   PubMed Web of Science ®Google Scholar
• Stuber E, Strober W, Neurath M: Blocking the CD40L-CD40 interactions in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion. J Exp Med 183: 693–698, 1996.
   PubMed Web of Science ®Google Scholar
• Klaus SJ, Pinchuk LM, Ochs HD et al: Costimulation through CD28 enhances T cell-dependent B cell activation via CD40-CD40L interaction. J Immunol 152: 5643–5652, 1994.
   PubMedGoogle Scholar
• de Boer M, Kasran A, Kwekkeboom J et al: Ligation of B7 with CD28/CTLA-4 on T cells results in CD40 ligand expression, IL-4 secretion and efficient help for antibody production by B cells. Eur J Immunol 23: 3120–3125, 1993.
   PubMed Web of Science ®Google Scholar
• Karandikar N, Vanderlugt CL, Walunas TL et al: CTLA-4: a negative regulator of autoimmune disease. J Exp Med 184: 783–788, 1996.
   PubMed Web of Science ®Google Scholar
• Lederman S, Yellin MJ, Geary AM et al: T-BAM/CD40-L on helper T lymphocytes augments lymphokine-induced B cell Ig isotype switch recombination and rescues B cells from programmed cell death. J Immunol 152: 2163–2171, 1994.
   PubMed Web of Science ®Google Scholar
• Liu Y-J, Joshua DE, Williams GT et al: Mechanism of antigen driven selection in germinal centers. Nature 342: 929–931, 1989.
   PubMed Web of Science ®Google Scholar
• Tsubata T, Wu J, Honjo T: B cell apoptosis induced by antigen receptor croos-linking is blocked by a T cell signal through CD40. Nature 364: 645–648, 1993.
   PubMed Web of Science ®Google Scholar
• Parry SL, Hasbold J, Holman M et al: Hypercross-linking surface IgM or IgD receptors on mature B cells induces apoptosis that is reversed by costimulation with IL-4 and anti-CD40. J Immunol 152: 2821–2829, 1994.
   PubMed Web of Science ®Google Scholar
• Schattner EJ, Elkon KB, Yoo D-H et al: CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway. J Exp Med 182: 1557–1565, 1995.
   PubMed Web of Science ®Google Scholar
• Wang Z, Karros JG, Howard RG et al: Induction of bcl-x by CD40 engagement rescues slg-induced apoptosis in murine B cells. J Immunol 155: 3722–3725, 1995.
   PubMedGoogle Scholar
• Ray SK, Putterman C, Diamond B: Pathogenic autoantibodies are routinely generated during the response to foreign antigen: a paradigm for autoimmune disease. Proc Natl Acad Sci USA 93: 2019–2024, 1996.
   PubMed Web of Science ®Google Scholar
• Gleichmann E, van Elven EH, van der Veen JPW: A systemic lupus erythematosus (SLE) like disease in mice induced by abnormal T-B cell cooperation. Preferential formation of autoantibodies characteristic of SLE. Eur J Immunol 12: 152–159, 1982.
   PubMed Web of Science ®Google Scholar
• Kammer GM, Khan I, Malemud C: Deficient type I protein kinase A isozyme activity in systemic lupus erythematosus T lymphocytes. J Clin Invest 94: 422–430, 1994.
   PubMed Web of Science ®Google Scholar
• Vassilopoulos D, Kovacs B, Tsokos GC: TCR/CD3 complex-mediated signal transduction pathway in T cells and T cell lines from patients with systemic lupus erythematosus. J Immunol 155: 2269–2281, 1995.
   PubMed Web of Science ®Google Scholar
• Albertini RJ, O’Neil JP, Nicklas JA et al.: Alterations of the hprt gene in normal human in vivo-derived 6-thioguanine resistant T lymphocytes. Nature 316: 369–371, 1985.
   PubMed Web of Science ®Google Scholar
• AUegretta M, Nicklas JA, Sriram S et ai: T cells responsive to myelin basic protein in patients with multiple sclerosis. Science 247: 718–721, 1990.
   Google Scholar
• Theocharis S, Sfikakis PP, Lipnick RN et ai: Characterization of in vivo mutated T cell clones from patients with systemic lupus erythematosus. Clin Immunol Immunopathol 74: 135–142, 1995.
   PubMedGoogle Scholar
• Dong X, Hamilton KJ, Satoh M et al.: Initiation of autoimmunity to the p53 tumor suppressor protein by complexes of p53 and SV40 large T antigen. J Exp Med 179: 1243–1252, 1994.
   PubMed Web of Science ®Google Scholar
• Koutouzov S, Cabrespines A, Amoura Z et al.: Binding of nucleosomes to a cell surface receptor: redistribution and endocytosis in the presence of lupus antibodies. Eur J Immunol 26: 472–486, 1996.
   PubMed Web of Science ®Google Scholar
• DeMagistris MT, Alexander J, Coggeshall M et ai: Antigen analog-Major histocompatibility complexes act as antagonists at the T cell receptor. Cell 68: 625–634, 1992.
   PubMed Web of Science ®Google Scholar
• Sloan-Lancaster J, Evavold BD, Allen PM: Th2 cell clonal anergy as a consequence of partial activation. J Exp Med 180: 1195–1205, 1994.
   PubMed Web of Science ®Google Scholar